Sinovac statement from WHO Director-General Ghebreyesus

class = “cf”>

At the press conference held at the organization’s headquarters in Geneva, Managing Director Ghebreyesus reiterated his call on world leaders to provide financial support for the Global Access Program for the new type of coronavirus vaccine (Kovid- 19) (COVAX), which was created to support low- and middle-income countries.

Ghebreyesus stressed the importance of donating vaccines to COVAX to immunize healthcare workers and priority groups in poor countries.

Expressing his satisfaction with the WHO approval for the emergency use of the new Sinovac vaccine developed by China, Ghebreyesus said: “Today, I am happy to announce that the Sinovac-CoronaVac vaccine has been placed on the WHO emergency use list after being determined to be safe and effective. ” mentionned.

Ghebreyesus pointed out that “the quality of the Sinovac vaccine is finalized” after two doses.

Pointing out that the Sinovac vaccine is also affordable due to its ease of storage, Ghebreyesus said the organization had given emergency use approval for the 8th Kovid-19 vaccine as well.

class = “cf”>

“It is now essential to quickly deliver these vital tools to the people who need them,” said Ghebreyesus. used the expression.

WHO announced on December 31 the first Kovid-19 vaccine produced by Pfizer-BioNTech, followed by the Oxford-AstraZeneca vaccine, the vaccine produced by the Indian Serum Institute (SII), the vaccine manufacturer of AstraZeneca, Astra ZenecaBio (South Korea), Moderna, Janssen and he gave emergency use approval to vaccines produced by the Chinese company Sinopharm.

Bigpara for cryptocurrency markets

Bigpara for cryptocurrency markets

Add a Comment